CFO
PFE icon

Cambient Family Office’s Pfizer PFE Stock Holding History

Cambient Family Office’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Sell
17,084
-5,403
-24% -$141K 0.05% 172
2026
Q1 		$631K Buy
22,487
+1,154
+5% +$30.7K 0.09% 134
2025
Q4 		$531K Buy
+21,333
New +$538K 0.08% 129

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cambient Family Office's PFE Position: Q2 2026 in Review

Cambient Family Office reduced its Pfizer (PFE) stake by 24% in Q2 2026, selling an estimated $141K and leaving 17,084 shares worth $411K. The position accounts for 0.05% of the portfolio, ranked #172.

Cambient Family Office first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $631K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cambient Family Office held 17,084 shares of Pfizer worth $411K as of Q2 2026.
  • Cambient Family Office sold 5,403 Pfizer shares in Q2 2026, an estimated $141K.
  • Pfizer made up 0.05% of Cambient Family Office's portfolio in Q2 2026, its #172 holding.
  • Cambient Family Office first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Cambient Family Office's Pfizer position peaked at $631K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.